ArticleCancer reports (Hoboken, N.J.)2025
A Unique Case of Poorly Differentiated Neuroendocrine Carcinoma With Brain and Bilateral Adrenal Metastases.
Article in Cancer reports (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmall-cell carcinoma is a highly malignant neuroendocrine neoplasm arising from cells of the endocrine and nervous systems, and usually of bronchogenic origin. When found in the retroperitoneum, these malignant cells are extremely rare and are mainly metastatic tumors. Adrenal glands are unusual sites of distant metastases, the common primary being bronchopulmonary and gastroenteropancreatic neuroendocrine tumors (NETs). We report a case of poorly differentiated neuroendocrine carcinoma (NEC) that was initially discovered in both adrenal glands. CASE: Our patient was a 68-year-old woman who presented with articular pain and severe chronic hemolytic anemia. Her workup comprised a contrast-enhanced computed tomography (CT) scan of the chest, abdomen, and pelvis, revealing a left adrenal mass lesion measuring 14 × 9 cm, and a concomitantly smaller right adrenal mass lesion arising from the gland and measuring 4 × 2 cm. In view of the size of the left adrenal mass we elected to offer her a complete resection. The patient therefore underwent a laparoscopic adrenalectomy. Histopathological examination of the specimen revealed a high-grade, poorly differentiated NEC of the adrenal gland, small-cell type, with tumor necrosis. A baseline evaluation comprised an FDG-PET CT scan revealing the contralateral adrenal tumor, which was also partially resected to leave the patient with some functional adrenal tissue and not render her Addisonian. Although we found no pulmonary primary, a bleb was seen on chest CT that we hypothesized was possibly a burn-out primary in the setting of an immunogenic tumor.
conclusionSurgery played a vital role in our case followed by combination of chemoimmunotherapy as per present recommendation of a small-cell tumor especially since the patient presented with atypical clinical manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.